ADMA BIOLOGICS, INC. (ADMA) Free cash flow 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$27.8MFY2025 · since FY2016: -$18.3M → $27.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $27.8M | -74.8% |
| FY2024 | $110.4M | +2641.3% |
| FY2023 | $4.0M | +105.5% |
| FY2022 | -$73.4M | +41.7% |
| FY2021 | -$125.9M | -9.7% |
| FY2020 | -$114.7M | -43.4% |
| FY2019 | -$80.0M | -23.5% |
| FY2018 | -$64.8M | -62.1% |
| FY2017 | -$39.9M | -117.8% |
| FY2016 | -$18.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADMA financial trends
ADMA RevenueADMA Net incomeADMA Net marginADMA Gross profitADMA Gross marginADMA Operating incomeADMA Operating marginADMA Operating cash flowADMA Capital expendituresADMA Return on equityADMA Stock buybacksADMA Dividends paidADMA Total assetsADMA Total liabilitiesADMA Shareholders’ equityADMA overview →